Citadel Advisors’s Evolv Technologies EVLV Stock Holding History
Bought
Maintained
Sold
Other funds holding EVLV
VCM
VPM
SPCM
DCI
EA
Citadel Advisors's EVLV Position: Q1 2026 in Review
Citadel Advisors increased its Evolv Technologies (EVLV) stake by 86% in Q1 2026, buying an estimated $4.13M and bringing the position to 1,522,823 shares worth $9.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3369.
Citadel Advisors first reported a position in EVLV in Q3 2021 and has held it in 18 quarters since. The position peaked at $22.9M in Q3 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.
- Citadel Advisors held 1,522,823 shares of Evolv Technologies worth $9.21M as of Q1 2026.
- Citadel Advisors bought 705,371 Evolv Technologies shares in Q1 2026, an estimated $4.13M.
- Evolv Technologies made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3369 holding.
- Citadel Advisors first reported a position in Evolv Technologies in Q3 2021 and has held it in 18 quarters since.
- Citadel Advisors's Evolv Technologies position peaked at $22.9M in Q3 2025.
- 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.